Shari A. Steinman, PhD | Psychiatrist.com

Letter to the Editor

Challenges in Testing Intranasal Ketamine in OCD

April 26, 2017

Reports have indicated that a single intravenous ketamine dose rapidly decreases OCD symptoms. These researchers planned a study of nasal ketamine administration for this purpose, but they quickly encountered...

Carolyn I. Rodriguez, Kyle A. B. Lapidus, Jordana Zwerling, et al

Letter to the Editor

Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial

March 23, 2016

Carolyn I. Rodriguez, Michael Wheaton, Jordana Zwerling, et al